lobbying_activities: 3056025
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3056025 | 40e74736-182a-4a21-bf3c-f2a6b7f36524 | Q3 | HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC | 17966 | EMERGENT BIOSOLUTIONS | 2023 | third_quarter | DIS | S.2624 and House Draft - Departments of Labor, Health and Human Services, and Education, and related agencies' Appropriations Bill, 2024 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and stockpiling of medical countermeasures, including Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; H.R. 3935 - Securing Growth and Robust Leadership in American Aviation Act - Section 527 - Emergency Medical Equipment on Passenger Aircraft; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; State opioid response (SOR) grant funding proposals; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; H.R. 2670 - National Defense Authorization bill (NDAA), 2024 - provisions related to biological and chemical defense and access to Naloxone. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2023-10-18T11:59:19-04:00 |